glp-1 vision changes Medications and NAION: What Patients Should Know About Sudden Loss Wegovy Vision Loss Lawsuit [2026

The SELECT trial results and subsequent research have generated excitement within the medical community, with experts suggesting a paradigm shift in how we approach CVD management for individuals with obesity

Oxygen and Aging

The goal is to integrate PA into the normal prescription workflow, enabling real-time eligibility checks and reducing manual steps

BMI above 40 (class 3 obesity) The highest starting BMI group can achieve enormous absolute weight loss with GLP-1 therapy

(2019) 30:98796.e6

Key moves include: Geographic expansion : Lilly has out-licensed tirzepatide to partners in Asia (e.g., in China and India) to accelerate uptake outside the U.S./EU